Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peroxiredoxins | 3 | 2015 | 106 | 0.920 |
Why?
|
| Mitochondria | 3 | 2016 | 174 | 0.560 |
Why?
|
| Acyl Coenzyme A | 1 | 2015 | 4 | 0.560 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2015 | 2 | 0.560 |
Why?
|
| Proline Oxidase | 1 | 2015 | 2 | 0.560 |
Why?
|
| Hydroxyproline | 1 | 2015 | 3 | 0.560 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2015 | 3 | 0.560 |
Why?
|
| Models, Molecular | 1 | 2015 | 178 | 0.530 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 81 | 0.460 |
Why?
|
| Cysteine | 1 | 2010 | 131 | 0.360 |
Why?
|
| Oxidation-Reduction | 4 | 2015 | 250 | 0.260 |
Why?
|
| Biocatalysis | 2 | 2015 | 19 | 0.260 |
Why?
|
| Protein Conformation | 3 | 2015 | 85 | 0.200 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 248 | 0.190 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 280 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2015 | 73 | 0.180 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 350 | 0.170 |
Why?
|
| Binding Sites | 2 | 2015 | 125 | 0.160 |
Why?
|
| Kinetics | 2 | 2015 | 205 | 0.150 |
Why?
|
| Animals | 6 | 2016 | 7297 | 0.150 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2016 | 51 | 0.140 |
Why?
|
| Lactones | 1 | 2016 | 11 | 0.140 |
Why?
|
| Acyl Carrier Protein | 1 | 2015 | 3 | 0.140 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2015 | 3 | 0.140 |
Why?
|
| Oxalates | 1 | 2015 | 2 | 0.140 |
Why?
|
| Fatty Acids, Volatile | 1 | 2015 | 7 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 10 | 0.140 |
Why?
|
| Molecular Weight | 1 | 2015 | 40 | 0.140 |
Why?
|
| Protein Engineering | 1 | 2015 | 17 | 0.140 |
Why?
|
| Hydrolysis | 1 | 2015 | 38 | 0.140 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 27 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2016 | 131 | 0.140 |
Why?
|
| Catalytic Domain | 1 | 2015 | 58 | 0.140 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 77 | 0.140 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 666 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2015 | 84 | 0.140 |
Why?
|
| Thiostrepton | 1 | 2015 | 2 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2016 | 47 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 109 | 0.130 |
Why?
|
| Peroxides | 1 | 2015 | 31 | 0.130 |
Why?
|
| Mice | 4 | 2015 | 2368 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2015 | 38 | 0.130 |
Why?
|
| Mutation | 2 | 2015 | 466 | 0.130 |
Why?
|
| Humans | 10 | 2016 | 29093 | 0.120 |
Why?
|
| Apoptosis | 1 | 2016 | 337 | 0.120 |
Why?
|
| Sulfinic Acids | 1 | 2013 | 11 | 0.120 |
Why?
|
| Oxidants | 1 | 2013 | 15 | 0.120 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 34 | 0.120 |
Why?
|
| Disulfides | 1 | 2013 | 34 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2013 | 126 | 0.120 |
Why?
|
| Mortierella | 1 | 2013 | 1 | 0.120 |
Why?
|
| Fungal Proteins | 1 | 2013 | 5 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 711 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2013 | 44 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2015 | 422 | 0.110 |
Why?
|
| Liver | 1 | 2015 | 464 | 0.110 |
Why?
|
| Receptor, EphA2 | 1 | 2012 | 12 | 0.110 |
Why?
|
| Ephrin-A1 | 1 | 2012 | 11 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 980 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2013 | 256 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 384 | 0.100 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2010 | 5 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 441 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 481 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2005 | 47 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 66 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 72 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 90 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2016 | 158 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 142 | 0.060 |
Why?
|
| Protein Binding | 2 | 2016 | 199 | 0.060 |
Why?
|
| Male | 3 | 2016 | 17807 | 0.060 |
Why?
|
| GTP Phosphohydrolases | 1 | 2003 | 7 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 25 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2016 | 573 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 680 | 0.050 |
Why?
|
| Rats | 2 | 2016 | 1604 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2015 | 666 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 301 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 71 | 0.040 |
Why?
|
| Fatty Acid Synthesis Inhibitors | 1 | 2016 | 3 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2016 | 225 | 0.040 |
Why?
|
| Peptides | 1 | 2016 | 118 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2016 | 36 | 0.030 |
Why?
|
| Hela Cells | 1 | 2015 | 78 | 0.030 |
Why?
|
| Catalase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 21 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2015 | 20 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 71 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 162 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 172 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 6 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2012 | 32 | 0.030 |
Why?
|
| Alanine | 1 | 2012 | 27 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 45 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 56 | 0.030 |
Why?
|
| Ligands | 1 | 2012 | 81 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2012 | 97 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 546 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 23 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2005 | 11 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2005 | 16 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 95 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2005 | 281 | 0.020 |
Why?
|
| Female | 2 | 2016 | 18164 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2003 | 2 | 0.010 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2003 | 3 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2003 | 8 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2003 | 9 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 212 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 249 | 0.010 |
Why?
|